key: cord-0311764-hu1ofv51
authors: de Oliveira, Lilian Gomes; de Souza Angelo, Yan; Yamamoto, Pedro; Carregari, Victor Corasolla; Crunfi, Fernanda; Reis-de-Oliveira, Guilherme; Costa, Lícia; Duque, Érica Almeida; Barreto dos Santos, Nilton; Almeida, Glaucia Maria; Firmino, Egidi Mayara; Paiva, Isadora Marques; Polonio, Carolina Manganeli; Zanluqui, Nagela Ghabdan; de Oliveira, Marília Garcia; Davanzo, Gustavo Gastão; Ayupe, Marina Caçador; Salgado, Caio Loureiro; de Souza Filho, Antônio Francisco; de Araújo, Marcelo Valdemir; Silva-Pereira, Taiana Tainá; de Almeida Campos, Angélica Cristine; Bentim Góes, Luiz Gustavo; dos Passos Cunha, Marielton; D’Império Lima, Maria Regina; Fonseca, Denise Morais; de Sá Guimarães, Ana Márcia; Minoprio, Paola Camargo; Munhoz, Carolina Demarchi; Cabrera Mori, Cláudia Madalena; Moraes-Vieira, Pedro Manoel; Cunha, Thiago Mattar; Martins-de-Souza, Daniel; Peron, Jean Pierre Schatzmann
title: SARS-CoV-2 Infection Impacts Carbon Metabolism and Depends on Glutamine for Replication in Syrian Hamster Astrocytes
date: 2021-10-24
journal: bioRxiv
DOI: 10.1101/2021.10.23.465567
sha: 0b6cc9a0bfbdd4be94f30980c8bc75f01b385013
doc_id: 311764
cord_uid: hu1ofv51

Coronaviruses belong to a well-known family of enveloped RNA viruses and are the causative agent of the common cold. Although the seasonal coronaviruses do not pose a threat to human life, three members of this family, i.e., SARS-CoV, MERS-CoV and recently, SARS-CoV2, may cause severe acute respiratory syndrome and lead to death. Unfortunately, COVID-19 has already caused more than 4.4 million deaths worldwide. Although much is better understood about the immunopathogenesis of the lung disease, important information about systemic disease is still missing, mainly concerning neurological parameters. In this context, we sought to evaluate immunometabolic changes using in vitro and in vivo models of hamsters infected with SARS-CoV-2. Here we show that, besides infecting hamster’s astrocytes, SARS-CoV-2 induces changes in protein expression and metabolic pathways involved in carbon metabolism, glycolysis, mitochondrial respiration, and synaptic transmission. Interestingly, many of the differentially expressed proteins are concurrent with proteins that correlate with neurological diseases, such as Parkinsons’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease. Metabolic analysis by high resolution real-time respirometry evidenced hyperactivation of glycolysis and mitochondrial respiration. Further metabolomics analysis confirmed the consumption of many metabolites, including glucose, pyruvate, glutamine, and alpha ketoglutarate. Interestingly, we observed that glutamine was significantly reduced in infected cultures, and the blockade of mitochondrial glutaminolysis significantly reduced viral replication and pro-inflammatory response. SARS-CoV-2 was confirmed in vivo as hippocampus, cortex, and olfactory bulb of intranasally infected hamsters were positive for viral genome several days post-infection. Altogether, our data reveals important changes in overall protein expression, mostly of those related to carbon metabolism and energy generation, causing an imbalance in important metabolic molecules and neurotransmitters. This may suggest that some of the neurological features observed during COVID-19, as memory and cognitive impairment, may rely on altered energetic profile of brain cells, as well as an unbalanced glutamine/glutamate levels, whose importance for adequate brain function is unquestionable.

Mild disease is observed in most patients, who develop fever, headache, and coughing. Some patients, however, evolve to severe acute respiratory syndrome (SARS), characterized by lung inflammation with intense myeloid cells inflammatory infiltrate, hyaline membrane formation and alveolitis, clearly evidenced by lung magnetic resonance imaging (MRI) 2,4,5 . This results in dyspnea, difficult breathing, and low oxygen saturation. Most severe cases evolve with cytokine storm and systemic organ failure 6 , mainly in people with comorbidities such as hypertension, obesity, and diabetes, probably either to altered immune responses or to the higher expression of angiotensin converting enzyme-2 (ACE-2) in the lungs 7 . Since January 30 th , 2020, when the WHO declared a state of emergency and international concern, more than 5,7 million people have died of COVID-19. Viral particles invade host cells using its Receptor Binding Domain (RBD) of the spike protein through the interacting with Angiotensin Converting Enzyme-2 (ACE-2), expressed mostly on type II pneumocytes but also on other cell types, including neurons, enterocytes and many others 8, 9 . Further, spike is cleaved in subunits S1 and S2 by the protease TMPRSS2 10 on the surface of host cells, promoting the fusion with cell membrane for further release of the genome into the cytoplasm. In the cytoplasm, ORF1a and ORF1b are translated from the (+) RNA strand into 16 non-structural proteins, whereas (-) RNA strands are used as template for replication and for the translation of sub-genomic RNAs. Sub-genomic RNAs are then translated into structural proteins, as spike (S), envelope (E), nucleocapsid (N) and membrane (M), that are assembled into viral particles and released to the extracellular space 11 . During this process, viral RNA may be sensed by innate immunity sensors, as RIG-I 12 and MDA-5 13, 14 leading to inflammasome activation and cytokine secretion. It triggers signaling pathways that culminate in the production of pro-inflammatory and anti-viral cytokines, as IL-1b, IL-6, TNF-α and type I interferons, which are exacerbated in patients evolving to cytokine storm, as reviewed 15 .

Conversely, this is associated with intense lung infiltration of myeloid cells, such as neutrophils 16 and monocytes, as well as of lymphocytes with high expression of the exhaustion markers, PD-1 and TIM-3 17 . Clearly, the immune response during COVID-19 has a dual role, as it may reduce viral burden, but also account for disease exacerbation 18 . These evidences show the complexity of COVID-19 as well as the difficulty in predicting worse disease outcomes.

In this context, despite being a respiratory disease, COVID-19 patients may develop several other manifestations 18 , including anosmia and ageusia 19 , suggesting an impact in the central nervous system. In fact, it has been demonstrated that SARS-CoV-2 infects olfactory sensory neurons (OSN) and uses the transmucosal route to reach brain tissue 20 . The neurological importance of SARS-CoV-2 infection is still a matter of debate. A retrospective study performed in Wuhan, China, from January to February 2020 analyzed 214 patients, of whom 36.4% developed neurological symptoms related to cerebrovascular events and impaired consciousness 21 . Since then, many case reports and cohort prospective studies have been published pointing to signs and symptoms of neurological alterations that range from the anosmia and ageusia, to leptomeningitis 22 , stroke, microvascular damage 23 , severe headache, encephalopathy 24 , and even peripheral Guillain-Barré Syndrome 25 . Histopathological analysis revealed multiple ischemic areas, encephalopathy, and microglial activation. Interestingly, recent reports have also pointed to residual psychiatric features in patients that recovered from COVID- 19 , as chronic fatigue, cognitive decline 26 , mood disorders and depression, in the so-called "brain fog" 27, 28 .

Whether these are direct viral effects or indirect results of systemic inflammation is a matter of controversy, and the real impact of SARS-CoV-2 to the human brain remains elusive.

In this sense, here we used in vitro and in vivo systems to evaluate immunometabolic and energetic changes using Golden Syrian Hamsters (Mesocricetus auratus) infected with SARS-CoV-2. We observed that the virus infects and replicates in hamster's astrocytes and further inducing a pro-inflammatory response. Interestingly, we observed that SARS-CoV-2 shifts main metabolic pathways, specially subverting the glutamine usage for enhanced replication.

Corroborating this, the blockade of glutaminolysis significantly impairs viral progeny. Also, respirometry confirmed intense metabolic activity in the presence of the virus, further corroborated by metabolomics. In vivo, we confirmed the presence of viral RNA in the cortex and hippocampus of infected animals, and consistent changes in the protein profile. Thus, here we suggest that the virus hijacks cellular carbon metabolism, especially glutamine consumption, for its own benefit, in detriment of a proper cellular metabolic function. Due to the importance of glutamatergic synapses for appropriate neuronal synapses, here we propose a correlation between SARS-CoV-2 infection over memory and cognitive impairment due to metabolic imbalance of important neurotransmitters, especially glutamate/glutamine. Moreover, our proteomic analysis showed a significant impact on carbon metabolism pathways consistent with brain diseases, such as Parkinson's Disease, Multiple Sclerosis, and long-term depression, which were also concordant with changes observe in COVID-19 deceased patients. This brings attention to a possible correlation of altered carbon and energy metabolism with the cognitive and memory impairment observed in COVID-19 patients.

SARS-CoV-2/SPPU-0691 (GenBank accession number MW441768) was obtained, isolated, and propagated at Scientific-Platform Pasteur-USP (SPPU) and used for the experiments in vitro.

The respiratory sample (naso-oropharyngeal swab) was acquired during the acute phase of infection and complying with the inclusion criteria for clinical suspicion of associated viral infection to SARS-CoV-2 adopted by the Ministry of Health of Brazil. In sum, viral stocks were generated in Vero CCL81 cells. Prior to infection, cells were maintained in DMEM Low glucose (LGC ® ) supplemented with 10% of fetal bovine serum (FBS) (Gibco ® ) and 1% penicillin/streptomycin (LGC ® ) at 37°C, 5% CO 2 . The initial inoculum (passage 1) was prepared to dilute the clinical samples (1:5) in non-supplemented DMEM low glucose (Gibco ® ). The inoculum was then added to the flask containing Vero cells and maintained for 1 hour at 37°C, following addition of fresh DMEM low glucose media supplemented with 2% FBS and 1% penicillin/streptomycin. The cell culture was observed for cytopathic effects on each day after the inoculation. When a prominent cytopathic effect was observed the cell culture supernatant was collected, centrifuged to remove debris (500g), and stored at -80°C as the first viral passage.

The same strategy was employed three times to obtain a fourth passage isolate. Fourth passage viral stocks were used in this study titrated by plaque-forming unit (PFU) assay, according to protocols described elsewhere 23 . SARS-CoV-2 strain human/BRA/SP02cc/2020 (GenBank access number: MT350282.1) was used in the in vivo experiments.

Primary astrocytes were obtained from Syrian hamster neonates at days 2-4 postpartum (dpp).

The protocols were approved by the Ethics Committee for Animal Research of University of Sao Paulo (CEUA nº 7971160320 / 3147240820) and all efforts were made to minimize animal suffering. Animals were obtained from the Department of Pathology, School of Veterinary Medicine and from the Animal Science Department of Preventive Veterinary Medicine and Animal Health from the University of São Paulo. Briefly, brains were harvested, and the meninges were removed following tissue digestion with 0.05% of trypsin (Gibco ® ) at 37 C for 10 minutes. Next, tissue was mechanically disrupted and centrifuged 500g for 5 minutes. Cells were then resuspended in DMEM Ham's-F12 (LGC ® ) supplemented with 10% FBS (Gibco ® ), 1% penicillin/streptomycin, 1% non-essential amino acids (LGC ® ), 1% sodium pyruvate (LGC ® ) and 1% L-glutamine (LGC ® ) and seeded in cultures flasks maintained overnight at 37°C, 5% CO 2 atmosphere . Cells were then washed with phosphate saline buffer (PBS) and replaced with fresh media. The media were changed every three days until the confluency was reached, when culture flasks were shaken at 200rpm for 3 hours at 37 C for detaching of microglia. Floating cells were removed, and the remaining attached cells were harvested for in vitro assays.

Primary astrocytes were infected with SARS-CoV-2 at MOI 0.1 for 1h at 37 C and 5% CO 2 atmosphere. After infection, inoculum was washed, and cells were incubated with fresh DMEM 

This study was conducted using the following drugs and inhibitors: 6-diazo-5-oxo-L-nor- Arbor, Michigan, USA).

For virus titration, Vero CCL81 cells were seeded in 24 well plates one day before the infection for adhesion. Supernatants from in vitro assays were serially diluted in pure DMEM low glucose and inoculated for 1 hour at 37°C. Next, the inoculum was removed and replaced with DMEM low glucose containing 2% FBS, 1% penicillin/streptomycin and 1% carboxymethylcellulose.

After 3 days, the media was removed, and the cells fixed with 3.7% formaldehyde overnight.

The cell monolayers were stained with 1% crystal violet for 15 minutes. The viral titer was calculated based on the count of plaques formed in the wells corresponding to each dilution expressed as plaque-forming units per mL (PFU/mL). TaqMan™ Gene Expression Assay (Cat. N. 4331182, ThermoFisher ® ) with specific primers/probes previously described 40 . The quantitative assay was performed using a standard curve produced with serial dilutions of SARS-CoV-2 RNA expressed on a Briggsian logarithm scale as genome equivalents per ug of total RNA. Gene expression assays were performed using Power SYBR® Green Master Mix (Cat. N. 4368577, ThermoFisher ® ) with primers described below. The median cycle threshold (C t ) value from experimental replicates and 2 -DDCt method were used for relative quantification analysis and all C t values were normalized to Actb. All qRT-PCR assays were performed on QuantStudio™ 3 Real-Time PCR System (Thermo Fisher ® ).

Actb_Hm

After infection hamster astrocytes were resuspended in lysis buffer (100mM Tris HCL, 150 mM NaCl, 1 mM EDTA, 1% Triton X) with freshly added protease and phosphatase inhibitors (Protease Inhibitor Cocktail, SIGMA®) and subjected to ultrasonication (3 cycles of 20s).

Samples were submitted to the FASP protocol (Distler U., and Tenzer S. 

Hamster's primary astrocytes were cultured as described above. Next, the medium was washed twice with phosphate-buffered saline (PBS) at physiologic pH and cells were collected with 600 

An XFe24 Extracellular Flux analyzer (Agilent ® ) was used to determine the bioenergetic profile.

Cells were plated at 2 x 10 4 cells per well in XFe24 plates 24h before infection with SARS-CoV-2. Glycolytic Stress and Mito Stress Tests were performed on XFe24 Bioanalyzer at 72 hpi. All assays were performed following manufacturer's protocols. Results were normalized to cell number.

Hamster astrocytes infected and uninfected were recovered, washed with PBS 1x and fixed with Glutaraldehyde 4% overnight. Samples were washed with PBS 1x and followed to dehydration process with acetone gradient, desiccation, and gold metallization. Finally, samples were analyzed in JOEL1010 transmission electron microscope. Generated images were loaded into Fiji software for further analysis. For TEM mitochondrial measurements, the images were filtered and manually measured for width and length.

For measurements of mitochondrial superoxide, the cells were stained with LIVE/DEAD™ Fixable Green (L34970; ThermoFisher ® , 15 min) and MitoSOX™ Red mitochondrial superoxide indicator (M36008; ThermoFisher ® ; 2.5uM, 10 min). Cells were then washed with warm 1X

PBS and fixed with 4% PFA for 15 minutes at 4C. Next, cells were analyzed using a Accuri C6

Plus (BD Biosciences ® ) cytometer and data analyzed using FlowJo X software.

On day 7 of astrocyte culture, 2 x 10 4 cell were seeded in a 24-well plate, after overnight incubation with culture media cells were fixed with ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.4 for 30 minutes. After antigen retrieval (Tris/EDTA-Tween-20 buffer -10mM Tris, 1mM EDTA, 0.05% Tween 20, pH 9 -for 30 minutes at 95°C, followed by 20 minutes at room temperature), cells were permeabilized with 0.5% Triton-X100 in PBS for 10 minutes, blocked with blocking solution (5% donkey serum + 0.05% Triton X-100 in PBS) (Sigma-Aldrich) for 2 hours at room temperature and incubated with primary antibodies: GFAP . For virus infection, the medium was removed, and the brain slices were exposed to 3x10 6 TCID50 of SARS-CoV-2 or an equivalent volume of mock medium. Infection was performed for 2h at 37°C and 5% CO2 in a biosafety level 3 laboratory. The inoculum was removed, the tissue was washed, and the slices were maintained in fresh medium at 37°C and 5%

CO2 until processing for subsequent analysis. This procedure was approved by the CEUA-FMRP (#066/2020).

Raw snRNA-seq data were obtained from frozen medial frontal cortex tissue from six post- 

Data was plotted and analyzed using the GraphPad Prism 8.0 software (GraphPad Software ® , San Diego, CA). For analyses between 2 groups, Student's t test was used. For comparisons among 3 or more groups, One-way ANOVA, followed by Tukey post hoc tests was used as described in figures legends. Differences were considered statistically significant when P value was <0.05.

We started our experiments by infecting brain slices of adult Syrian golden hasmters with 

Next, we evaluated whether SARS-CoV-2 triggers the production of pro-inflammatory cytokines in hamster primary astrocytes. Consistent with the literature, we observed that Il-1b, Il-6, Tnf-a and Ifn-a are significantly increased 72 hpi at MOI 0.1 (Figure 2A-D) . Confirming that type I interferons are active, we also observed that the interferon-stimulated genes (ISGs), Isg20, Figure 2C) .

Consistently, most of these changes are related to alterations in the overall metabolic profile of the cells, including carbon metabolism, glycolysis/gluconeogenesis, and pentose phosphate pathway (Supplementary Figure 2D) .

Because SARS-CoV-2 infection induced important changes in carbon metabolism-related proteins, we next validated these findings. First, we infected the cultures with SARS-CoV-2 (MOI 0.1) and assessed mitochondrial morphology through transmission electron microscopy (TEM). As shown in Figure 3A , mitochondria from SARS-CoV-2 samples are more fragmented than in control cultures. This was associated with increased mitochondrial reactive oxygen species (ROS) production at 24 and 72 hpi ( Figure 3B ). Next, we performed high resolution real-time respirometry at 72 hpi. Conversely, we observed that both glycolytic and non-glycolytic acidification were increased in the presence of the virus ( Figure 3C ), although, basal and maximal mitochondrial respiration were not statistically different, despite the trend ( Figure 3D ).

To 

To further determine which specific metabolic pathway is more important in favoring SARS-CoV-2 replication, we treated infected cultures with inhibitors of fatty acid metabolism (Etomoxir, 3uM), glutaminolysis (L-DON, 50uM) and glycolytic pathways (2-DG, 5mM) as illustrated in Figure 5A . As shown in Figure 5B , blockade of glycolysis with 2-deoxyglucose (2-DG) did not significantly change SARS-CoV-2 replication at 24-72 hpi., further corroborated by PFU assay (Figure 5B right) . Also, the use of etomoxir, an inhibitor of the carnitine palmitoyltransferase 1a (CPT-1a), indicates low dependence of mitochondrial fatty acid oxidation ( Figure 5B ). Interestingly, however, the inhibition of mitochondrial glutaminase (GLS)

with L-6-Diazo-5-oxo-norleucine (L-DON), significantly decreased SARS-CoV-2 replication ( Figure 5B ) and the release of viral particles ( Figure 5C ). Accordingly, the addition of glutamine (2mM) in the absence of glucose significantly increased viral replication, whereas glucose (17mM) was not able to do so ( Figure 5C ).

Next, we evaluated the expression of proinflammatory cytokines during the treatment with L-DON. Blockade of GLS with L-DON decreased the transcription of Il-1b, Il-6 ( Figure   5D -E), and Ifn-a ( Figure 5F ) but not Tnf-a ( Figure 5G ) when compared to non-treated groups.

This is in accordance with the reduction of the ISGs, Ace-2, Isg20 and Iftm3 ( Figure 5H-J) .

These results evidence that glutamine is important for viral replication and the blockade of glutaminolysis reduces viral loads which in turn reduces type I IFN and pro-inflammatory responses

It has already been demonstrated that the Syrian hamster is a permissive model to nasal infection with SARS-CoV-2 36 . Thus, we decided to use this model to address whether the virus reaches important areas of the brain, such as cortex, hippocampus, and olfactory bulb after intranasal infection with 10 5 TCID 50, as illustrated. Consistently, we confirmed the presence of SARS-CoV-2 in these areas, both at 3-, 5-, 7-and 14-days post-infection (dpi) ( Figure 6A ) with higher titers at day 3. We also observed increased expression of the same pro-inflammatory cytokines evaluated in vitro, Il-6, Il-1b and Tnfa, as well as the ISGs Isg20 and Iftm3, both in the hippocampus ( Figure 6B ) and cortex ( Figure 6D ). Interestingly, although Il-1b was increased in the cortex ( Figure 6D ), no difference was observed in the hippocampus ( Figure 6B ) the same was observed for Il-6 which is increased the hippocampus ( Figure 6B ) but not in the cortex ( Figure 6D ). As expected, proteomic analysis of these brain samples showed that in the hippocampus, DEPs correlated with pathways of oxidative phosphorylation, long-term potentiation, dopaminergic and cholinergic synapses, among others ( Figure 6C ). In the cortex, DEPs correlated with important neuronal function, as synaptic vesicle cycle, dopaminergic and

GABAergic synapses, as well as to neurological features of brain diseases, as Parkinson's disease and long-term depression ( Figure 6E ). To further confirm whether these changes are in accordance with those observed in human COVID-19 patients, we compared the DEPs from our in vivo proteomic analysis with a data set from the literature that analyzed more than 64,000 single cells obtained from the frontal cortex and choroid plexus of 8 deceased COVID-19 patients ( Figure 6F ). We found a strong convergence of important signaling pathways enriched in both datasets, such as those for metabotropic and ionotropic glutamate receptors, Wnt signalling and adrenergic activation. Also, important physiological processes were related between hamster and human samples, as synaptic vessel trafficking, glycolysis, and inflammation, which were further consistent with the enrichment of DEPs correlated to brain diseases, as Parkinson's disease, Huntington's disease, and Alzheimer's disease ( Figure 6G ). We also performed qPCR for the expression of glutamate transporters and receptors in the hippocampus and cortex of the infected animals, but we detected no differences (Supplementary Figure 4) . Altogether, our data support the hypothesis that important changes in protein expression and carbon metabolism is occurring in the brains of infected Golden Syrian hamsters, and these changes may share similarities to those observed in COVID-19 patients.

Although the great majority of people infected with SARS-CoV-2 develop only mild or asymptomatic disease, COVID-19 has already taken more than 5.7 million lives worldwide.

Moreover, although it is essentially a lung disease, unconventional neurological symptoms have been reported since the beginning of the pandemic, from mild anosmia and ageusia 19, 21 , to more severe neurological cases of encephalitis, cerebrovascular disease, ataxia and seizures 37 . Most recently, the description of the "long COVID-19" and the "brain fog", still intrigues physicians and researchers, as cases of cognitive impairment, memory impairment, disorientation and depression have been increasing, evidencing the complexity of the disease 27, 38 .

In this context, here we show that SARS-CoV-2 infects the central nervous system of Huntington disease, Parkinson disease and long-term depression, whose symptoms are similar to those observed in many COVID-19 patients.

The fact that viruses actively hijack cellular metabolism is well known, as for CMV, HSV, HIV, vaccinia virus, and many others, as reviewed 39 . This occurs either to facilitate viral replication and virion assembling or to evade local immune responses. Although the presence of replicating SARS-CoV-2 in human brains is still a matter of debate, its impact on neurological function, as memory and cognition, has become unquestionable. In this sense, the relevance of glutamatergic synapses for appropriate brain function is fundamental, as more than 90% of excitatory synapses are mediated by glutamate ionotropic and metabotropic receptors. Due to its importance, glutamate is constantly recycled within the cell, either as a neurotransmitter, as glutamate and aspartate, and transported to pre-synaptic vesicles by vesicular glutamate transporters (Vglut), or following its conversion from glutamine to glutamate and then to alphaketoglutarate to fuel the TCA cycle during cataplerosis. This conversion is essential and happens extensively in astrocytes and neurons through the function of glutaminase. Of note, conversion from glucose and glutamine is the major source of glutamate in the brain, as very little is absorbed from the blood circulation. During certain circumstances, this balance may shift from one side to another, such as during infection or neurodegenerative diseases. Thus, it is clear that the balance between glutamate and glutamine plays a pivotal role in both synaptic transmission and energy acquisition for proper neuronal activity, shifting from vesicular neurotransmission to catapletorosis.

Consistently, we showed that SARS-CoV-2 replication in hamster glial cells significantly changes the levels of glutamine and alpha-ketoglutarate, as assessed by metabolomics. Also, glucose and TCA cycle components were reduced, whereas viral replication increases along with cytokine secretion. This is consistent with our previous findings in monocytes 40 . However, here we show that along with increased glycolysis, astrocyte infection with SARS-CoV-2, also used glutamine as a source of carbon. Interestingly, however, viral replication was independent of glycolisys, as 2-DG treatment did not impact viral replication. However, here we show that SARS-CoV-2 replication depends on glutamine, as the blockade of glutaminolysis with 6-Diazo-5-oxo-L-norleucine (DON) significantly reduced viral replication, and consequently, the production of inflammatory cytokines. This is also consistent with recent reports showing that SARS-CoV2 infection alters the expression of many TCA cycle proteins as well as their metabolites in lung epithelial cells 41 . Thus, it seems clear that SARS-CoV-2 impacts the overall status of protein expression, specifically of those involved in carbon and energy metabolism.

And these changes as pivotal for proper brain function. Thus, to our knowledge, this is the first report to demonstrate the impact of COVID-19

over the metabolic and proteomic profile of brain cells, specifically astrocytes. Moreover, we

show that SARS-CoV-2 benefits from glutamine as an important source of energy, which in fact has already been shown for vaccinia virus 45 Colors represents the protein z-score. DEPs from proteomic data submitted to KEGG database analysis (I). The nodes in gray represent major pathways and the color of the genes the z-score (red to blue). Cultures performed in triplicates and graphs representative of two experiments. were performed by t-test and p<0.05 was considered significant. Illustrative scheme of data generation from the comparison of our hamster proteomic data to human data set (F). The generated data were fed into an alluvial graph connecting the DEPs from hamster brain proteomics with significant ontology pathways of public human brain single-cell sequencing data sorted by specific brain cell populations (G). OPC = Oligodendrocyte progenitor cell. 

Seasonality of Respiratory Viral Infections: Will COVID-19 Follow Suit? Front. Public Heal

Clinical Characteristics of Coronavirus Disease 2019 in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Article SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

The coding capacity of SARS-CoV-2

SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO

RIG-i, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

The trinity of COVID-19: immunity, inflammation and intervention

SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

Extrapulmonary manifestations of COVID-19

Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Acute Cerebrovascular Disorders and Vasculopathies Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter

Spectrum of neurologic & neuroimaging manifestation in COVID-19

Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19

Cognitive decline among individuals with history of mild symptomatic SARS CoV 2 infection. A longitudinal prospective study nested to a population cohort

Neurologic Syndromes Predict Higher In-Hospital Mortality in COVID-19

CNS implications of COVID-19: A comprehensive review

Integrated analysis of multimodal single-cell data

Normalization and variance stabilization of single-cell RNAseq data using regularized negative binomial regression

Fitting Gamma-Poisson generalized linear models on single cell count data

MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

scREAD: A Single-Cell RNA-Seq Database for Alzheimer's Disease

Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)

Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Progress in Research on SARS-CoV-2 Infection Causing Neurological Diseases and Its Infection Mechanism

Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

MYC-induced reprogramming of glutamine catabolism supports optimal virus replication

The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis

Dysregulation of brain and choroid plexus cell types in severe COVID-19

COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway

Vaccinia Virus Requires Glutamine but Not Glucose for Efficient Replication